Semaglutide works by mimicking the action of GLP-1, a hormone produced in the intestines that regulates blood sugar levels by stimulating insulin release, reducing glucagon secretion (a hormone that raises blood sugar levels), slowing down stomach emptying, and promoting feelings of fullness or satiety. By activating the GLP-1 receptors, Ozempic helps improve insulin sensitivity and lowers blood sugar levels, leading to better glycemic control in people with type 2 diabetes. It is usually prescribed in combination with diet and exercise to help manage blood glucose levels in those who have not achieved sufficient control with other oral antidiabetic medications or insulin. Ozempic has been studied and approved as a treatment for weight management in people with obesity or overweight, even in those without diabetes, under the brand name Wegovy. The weight management dose of Ozempic is higher than the dose used for diabetes management. Ozempic is available as an injectable medication and is typically administered once a week using a prefilled pen device. The specific dose and administration schedule are determined by a healthcare professional based on an individual’s medical history, response to treatment, and overall health goals.
